ImmunoGen Inc (NASDAQ:IMGN)

10.36
Delayed Data
As of Apr 25
 +0.37 / +3.70%
Today’s Change
3.73
Today|||52-Week Range
13.41
+61.62%
Year-to-Date

Today’s Trading

Previous close9.99
Today’s open10.05
Day’s range9.94 - 10.57
Volume2,316,889
Average volume (3 months)3,179,453
Market cap$1.5B
Data as of 4:00pm ET, 04/25/2018

Growth & Valuation

Earnings growth (last year)+45.86%
Earnings growth (this year)-15.12%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+168.41%
P/E ratioNM
Price/Sales5.45
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...+0.20+1.75%
NTLAIntellia Therapeutic...+0.34+1.69%
BOLDAudentes Therapeutic...-1.63-4.39%
AMAGAMAG Pharmaceuticals...+0.65+3.36%
Data as of 4:00pm ET, 04/25/2018

Financials

Next reporting dateMay 4, 2018
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$115.4M
Annual profit (last year)-$96.0M
Net profit margin-83.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts